Skip to content

Clinical trials

Completed Phase 1/2 Autism Spectrum Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autism Spectrum Disorder Phase: Phase 1/2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20091
20141
20153
20161
20181
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Arizona State University1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Fenix Innovation Group1
National Institute of Mental Health (NIMH)1
OptiNose AS1
Russian Academy of Medical Sciences1
State-Financed Health Facility "Samara Regional Medical Center Dinasty"1
The University of Texas Health Science Center, Houston1
University of California, Los Angeles1
University of California, San Diego1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autism Spectrum Disorder11
Autistic Disorder3
Asperger Syndrome1
Attention Deficit Disorder with Hyperactivity1
Child Development Disorders, Pervasive1
Cognition Disorders1
Cognitive Dysfunction1
Constipation1
Developmental Disabilities1
Diarrhea1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.